Radioquimioterapia de la enfermedad limitada del carcinoma pulmonar de célula pequeña. ¿Tratamiento concomitante en protocolos asistenciales?
- 40 Downloads
Combined radiochemotherapy in localised small-cell lung cancer. Concurrent treatment protocols?
We retrospectively reviewed our institution’s database to investigate the outcome and impact of combined radiochemotherapy (RT/CT; concomitant or in sequence) in localised small-cell lung cancer (L-SCLC).
Material and methods
Between January 1995 to November 1999, 79 patients with L-SCLC received combined RT/CT at our Institution. RT was delivered concurrently or sequentially following the CT. Patients with treatment response received additional prophylactic cranial irradiation (PCI).
Of the patients treated, 54% had received concurrent CT/RT compared to 46% receiving RT following the CT. PCI was administered to 80% of the patients. Complete response was observed in 66% of patients. With a median follow up of 30 months, median overall survival was 15.9 months; 14.3 months for patients who received RT following CT and 21.6 months for those receiving concurrent CT/RT. The type of schedule of combined radiochemotherapy was an independent prognostic factor for survival free of local recurrence, as was additional PCI for distant metastasis-free survival.
Our results are similar to those reported previously in the literature. The main point of interest is that our patients were non-selected. We strongly support the use of concurrent CT/RT so as to achieve results comparable to the best in the literature.
Key wordslung cancer small cell localised disease radiotherapy chemotherapy
Unable to display preview. Download preview PDF.
- 2.Warde P, Payne D. Does radiotherapy radiation improve survival and local control in limited-stage small cell carcinoma of the lung? J Clinc, Oncol. 1992;10:890–5.Google Scholar
- 9.International Comission on Radiological Units and Measurements. Prescribing, recording and reporting photon beam therapy. ICRU Report No 50; 1993.Google Scholar
- 11.Cancer Therapy Evaluation Program. Common toxicity Criteria, version 2.0. Bethesda, USA; 1999.Google Scholar
- 18.Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group study 9104. J Clin Oncol. 2002; 20:3054–60.PubMedCrossRefGoogle Scholar